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OBJECTIVE — Infectionmaybeatype2diabetesriskfactor.Periodontaldiseaseisachronic
infection. We hypothesized that periodontal disease was related to A1C progression in diabetes-
free participants.
RESEARCH DESIGN AND METHODS — The Study of Health in Pomerania (SHIP) is
apopulation-basedcohortinGermanyincluding2,973diabetes-freeparticipants(53%women;
aged 20–81 years). Participants were categorized into four groups according to increasing
baseline periodontal disease levels (percentage of sites per mouth with attachment loss 5 mm,
determined a priori); sample sizes for each respective category were 1,122, 488, 463, and 479
(241 participants were edentulous). Mean absolute changes (year 5 minus baseline) in A1C
(A1C) were regressed across periodontal categories while adjusting for confounders (e.g., age,
sex, smoking, obesity, physical activity, and family history).
RESULTS — Across baseline periodontal disease categories, A1C  SEM values were
0.023  0.02, 0.023  0.02, 0.065  0.03, and 0.106  0.03 (Ptrend  0.02), yielding an
approximate ﬁvefold increase in the absolute difference in A1C when dentate participants in
the highest versus lowest periodontal disease category were compared; these results were
markedly stronger among participants with high-sensitivity C-reactive protein 1.0 mg/l
(Pinteraction  0.01). When individuals who had neither baseline periodontal disease nor dete-
riorationinperiodontalstatusat5yearswerecomparedwithindividualswithbothpoorbaseline
periodontalhealthandlongitudinalperiodontaldeterioration,meanA1Cvalueswere0.005vs.
0.143% (P  0.003).
CONCLUSIONS — Periodontal disease was associated with 5-year A1C progression, which
was similar to that observed for a 2-SD increase in either waist-to-hip ratio or age in this
population.
Diabetes Care 33:1037–1043, 2010
C
hronic infections are a potentially
novel risk factor for diabetogenesis
(1). Speciﬁcally, there is a known
association between periodontal infec-
tions and type 2 diabetes, although the
temporality and mechanisms of this asso-
ciation remain uncertain (2).
Toexaminethetemporalityofthisas-
sociation, data from the First National
HealthandNutritionExaminationSurvey
(NHANESI)wererecentlyanalyzedtoex-
plore whether baseline clinical periodon-
tal status predicted incident diabetes
among 9,296 initially diabetes-free par-
ticipants (1). It was reported that baseline
periodontal status was a strong predictor
of incident diabetes during 20 years of
longitudinal follow-up. However, the ab-
sence of laboratory A1C or fasting plasma
glucose assessments in NHANES I data
precludedexaminationoftheinﬂuenceof
periodontal status on glycemia. Conse-
quently,thepotentialforadiagnosticbias
remained; i.e., undiagnosed diabetes
might have preceded (and caused) base-
line periodontal disease but was subse-
quently diagnosed and erroneously
deﬁned as incident.
To enable a more precise delineation
of the natural history of associations be-
tweenperiodontalinfectionsanddiabeto-
genesis, we examined whether baseline
clinical periodontal status is associated
with 5-year A1C progression among dia-
betes-free individuals. We tested this hy-
pothesis among participants in the Study
of Health in Pomerania (SHIP).
RESEARCH DESIGN AND
METHODS— SHIP is a population-
based prospective cohort in East Ger-
many involving the cities of Greifswald,
Stralsund, and Anklam and 29 surround-
ing villages; the 1995 population in this
catchment area was 212,157. From each
ofthesecities,Germansubjectswithmain
residency in the area were randomly
drawn, proportional to each community
population and stratiﬁed by age and sex.
A representative sample of 7,008 adults
aged 20–79 years were invited to partici-
pate. This two-stage cluster sampling
method was adopted from the Multina-
tionalMonitoringofTrendsandDetermi-
nants in Cardiovascular Disease
(MONICA) Project, Augsburg, Germany,
and yielded 12 5-year age strata (20–81
years)forbothsexes.Afterremovalof746
individuals (126 died, 615 moved away,
and 5 had severe medical problems),
6,262 inhabitants were invited. The ﬁnal
sampleincluded4,310individuals,yield-
ing a 68.8% participation rate (3). There
were 130 passive nonrespondents due to
migration and 231 deceased subjects be-
tween the two examinations. Of the re-
maining 3,949 eligible individuals, 649
were active nonrespondents and 3,300
subjects were reexamined, resulting in an
83.6% follow-up rate (4). Participants
wereexcludedfromthecurrentanalysisif
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(n  219), deﬁned as either self-report,
physician-diagnosed, or A1C 6.5%; 2)
missing A1C (n  74); 3) missing peri-
odontal data (n  136) (5); or 4) missing
confounder data (n  78). The current
analysis included 2,793 participants.
The study was approved by the insti-
tutional review board of the University of
Greifswald. All participants provided
written informed consent.
Oral examination
Calibrated licensed dentists performed the
oral examinations, including a full-mouth
tooth count. In SHIP-0 the periodontal
probePCP11(Hu-Friedy,Chicago,IL)and
in SHIP-1 the periodontal probe PCP 2
(Hu-Friedy)wereusedtoassessperiodontal
probing depth (PPD) and clinical attach-
ment loss for examined teeth. Measure-
ments were taken at four sites per tooth
(mesiobuccal, midbuccal, distobuccal, and
midlingual), using the half-mouth method
ontherightorleftsideinalternatesubjects.
On the same teeth, coronal caries were
scored visually and with the periodontal
probe. Caries and missing teeth were regis-
teredbysurfaceandthedecayed/ﬁlledteeth
(DFT) index was calculated according to
World Health Organization criteria. Yearly
calibration exercises (6) yielded an intra-
classcorrelationof0.82–0.91perexaminer
andaninterratercorrelationof0.84relative
to attachment loss.
A1C measurement
Nonfasting blood samples were analyzed at
one laboratory that participated in the ofﬁ-
cial Germany INSTAND round-robin tests
for quality assurance in analytical laborato-
ries, at least semiannually, and internal
quality controls were measured daily. At
both visits, A1C was measured by cation-
exchange chromatography (high-
performance liquid chromatography) with
spectrophotometric detection (Diamat ana-
lyzer; BioRad, Munich, Germany) and a co-
efﬁcient of variation of 1.5%.
Risk factor assessment
Participants were queried by computer-
aided face-to-face interviews on sociode-
mographic characteristics, medical
histories, and medication use, i.e., an-
tidiabetes drugs (Anatomical Therapeutic
Chemical [ATC] code A10) and corticoid
drugs (ATC codes A01AC, A07EA, D07,
D10AA, G01B, H02, M01BA, and
R01AD). A self-administered question-
naire assessed region (rural versus urban)
and education level (10, 10, or 10
years of schooling). Leisure-time physical
activity was reported as 2, 1–2, or 1
h/week or no activity and was then con-
verted into METs (7). Smoking behavior
was assessed with a validated question-
naireandcategorizedasnever/occasional,
former,orcurrentsmoker(7).Familyhis-
toryofdiabeteswasdeterminedbyasking
whether parents or siblings had diabetes.
Height and weight were determined
using calibrated scales. Waist circumfer-
ence was measured at the narrowest place
between the last rib and the highest part
of the abdomen. Hip circumference was
determined as the greatest circumference
betweenthehighestpointoftheiliaccrest
and the crotch.
Blood pressure was measured three
times using a calibrated semiautomatic
sphygmomanometer (HEM-705CP; Om-
ron,Tokyo,Japan).Theaverageofthelast
two measurements was used for analysis.
High-sensitivity C-reactive protein (hs-
CRP) was determined in serum by particle-
enhanced immunonephelometry (hs-CRP
kit; Dade Behring, Deerﬁeld, IL) with a test
sensitivity of 0.2 mg/l. Triglycerides were
determined enzymatically using reagents
from Roche Diagnostics (Hitachi 717;
Roche Diagnostics, Mannheim, Germany).
Plasma ﬁbrinogen concentrations were as-
sayed according to Clauss using an Electra
1600 analyzer (Instrumentation Labora-
tory, Barcelona, Spain). White blood cell
(WBC) count was measured by the imped-
ance measurement method using the
Coulter principle (Coulter MaxM; Coulter
Electronics, Miami, FL).
Statistical analysis
Analyses were performed using SAS for
Windows (version 9.2; SAS Institute,
Cary, NC). PROC SURVEYREG was used
to generate variance estimates appropri-
ate for the clustered design.
Periodontal categorizations were cre-
ated to provide a meaningful contrast in
exposure while maintaining reasonable
samplesizebalanceacrosscategories.The
primary exposure variable was the per-
centage of periodontal sites with attach-
ment loss (AL) 5 mm at baseline (%AL
5 mm), which was determined a priori
(5).Dentateparticipantswerecategorized
intofourgroupsbasedon%AL5mmas
follows:1)1,122participantswithoutany
5-mm attachment loss who were consid-
eredperiodontally“healthy”(ALI);2)488
participants with %AL 5 mm, ranging
from 1 to 8% (ALII); 3) 463 participants
with%AL5mm,rangingfrom9to33%
(ALIII); 4) 479 participants with %AL 5
mm, ranging from 34 to 100% (ALIV);
and 5) 241 edentulous participants
formed a ﬁfth category (7,8).
Three alternate periodontal exposure
deﬁnitions were also considered. First,
baseline mean PPD was categorized into
four groups as follows: 1) 1.04  mean
PPD  2.00 mm (PPDI); 2) 2.01 
mean PPD 2.34 mm (PPDII); 3) 2.35 
mean PPD  2.75 mm (PPDIII); and 4)
2.76  mean PPD  7.25 mm (PPDIV).
Second,dentateparticipantswerecatego-
rized into tooth count tertiles (26–28,
21–25, and 1–20 teeth); edentulous par-
ticipants formed a fourth category. Fi-
nally, dentate participants with
longitudinal periodontal data were cate-
gorized into four groups according to
5-year change (follow-up  baseline) in
the percentage of sites with attachment
loss 5m m( %AL 5 mm) as follows:
1)ALI:565participantswithimproving
periodontal health (%AL 5m m 0);
2) ALII: 887 participants without any
change in periodontal status (%AL 5
mm  0); 3) ALIII: 423 participants
with %AL 5 mm, ranging from 1 to
8%; and 4) ALIV: 437 participants with
%AL 5 mm, ranging from 9 to 100%.
To address the speciﬁcity of any observed
associations to periodontal infection, we
alsoassessedtheassociationbetweenper-
centage of decayed/ﬁlled teeth (%DFT)
and A1C change.
Multivariable linear regression mod-
els were used to examine the association
between periodontal status (baseline
and/or change) and absolute 5-year A1C
change (A1C) (calculated as year 5
%A1C  baseline %A1C). Subgroup
analyses were performed, removing ex-
treme A1C changes to reduce the poten-
tial for biased statistical inferences due to
possible A1C normality violations. To
reduce the potential for age-related con-
founding, we also performed stratiﬁed
analyses in three age strata deﬁned by 20-
year age ranges (20–39, 40–59, and 60
years). Interaction models assessed the
statistical evidence of effect modiﬁcation
between periodontal status and systemic
inﬂammatory variables.
RESULTS
General characteristics
Participants were Caucasian, aged 48 
15 years (mean  SD), and 53% female.
Baseline periodontal disease (%AL 5
mm) was highly correlated with age (r 
0.50, P  0.0001) and was associated
withseveralsociodemographic,behavior/
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Among dentate participants, the mean
number of teeth (excluding third molars)
was 21  6 after age adjustment. On av-
erage, 17% of sites per mouth had attach-
ment loss 5 mm, which was higher
among men (18%) than among women
(13%) (P  0.0001).
Amongparticipantswithlongitudinal
periodontal measures (n  2,312), mean
absolute 5-year change in %AL 5m m
was2.314%(P0.0001)witharange
of75to70%.Five-yearchangeinmean
PPD was 0.08  0.50 mm (P 
0.0001). Baseline %AL  5m mw a s
weakly and inversely correlated with
change in the same variable (r  0.05,
P  0.008), whereas baseline mean PPD
was positively correlated with 5-year
change in %AL  5m m( r  0.08, P 
0.0001). Men, current smokers, and
younger participants were more likely to
experienceadeclineinperiodontalhealth
during follow-up. A1C was 0.05 
0.59%(range4.2to6.5%);98%ofA1C
changeswere1.0%and1.0%.After
multivariable adjustment, the following
nonperiodontal variables were associated
with A1C (P  0.05): waist-to-hip ratio
(WHR), ﬁbrinogen, hs-CRP, and former
smoking (Table 2).
Baseline periodontal or tooth loss
status and A1C change
Participantsinthefourthversusﬁrst%AL
5mmcategoryexperiencedan0.08%
greater 5-year increase in A1C (P  0.02)
(Table3,model4).A1Cwasaccelerated
by 0.10% among edentulous partici-
pants, relative to periodontally healthy
participants (P0.05). WhenA1C was
compared between participants in the
fourth versus ﬁrst attachment loss cate-
gory among those aged 20–39 years, the
absolute difference was 0.08% (P 
0.04). Findings were consistent among
participants aged 40–59 years (0.10%,
P  0.005) and those aged 60 years
(0.07%, P  0.27). There was evidence
for an interaction between %AL 5m m
and hs-CRP (Pinteraction  0.01), in which
the increase in A1C with higher %AL
5 mm was stronger among participants
withhs-CRP1.0mg/lthaninthosewith
hs-CRP 1.0 mg/l (Fig. 1). Trends were
consistent when ﬁbrinogen was consid-
ered as the effect modiﬁer (Pinteraction 
0.24) but less clear for WBC count
(Pinteraction  0.66) as shown in Fig. 1.
Respective A1C changes in the ﬁrst
to fourth quartiles of mean PPD were
0.001, 0.050, 0.033, and 0.107%
(Ptrend  0.01 after multivariable adjust-
ment as in Table 3, model 4). Mean A1C
changes across four categories of baseline
tooth count were 0.09% (26–28 teeth),
Table 1—Characteristics across categories of periodontal disease (%AL >5 mm), adjusted for age and sex: SHIP, 1997–2006
ALI
(0  0%)*
ALII
(4  2%)*
ALIII
(18  7%)*
ALIV
(62  21%)* Edentulous
n 1,122 489 463 479 241
Sociodemographic
Age† 38  0.3 47  0.5 53  0.5 59  0.5 68  0.7
Female sex† 61 50 51 40 48
9 years education 26 25 34 44 53
9–10 years education‡ 49 53 51 45 41
10 years education† 25 22 15 11 6
Lifestyle and behavioral
Former smokers† 38 36 29 29 28
Current smokers† 13 24 31 42 42
Pack-years smoking† 5  0.4 7  0.6 9  0.6 13  0.6 13.0  0.9
Physical activity (METs/day) 1,900  28 1,950  37 1,907  38 1,893  40 1,797  59
Region (urban vs. rural)‡ 63 63 62 54 50
Medical
BMI (kg/m
2) 26.7  0.15 26.8  0.19 27.2  0.20 27.3  0.21 27.1  0.31
WHR† 0.85  0.002 0.86  0.003 0.87  0.003 0.87  0.003 0.86  0.004
Systolic blood pressure (mmHg)‡ 133  0.6 135  0.8 134  0.8 135  0.9 138  1.3
Diastolic blood pressure (mmHg)† 83  0.4 85  0.5 85  0.5 84  0.5 82  0.8
A1C (%)‡ 5.20  0.02 5.23  0.02 5.28  0.02 5.25  0.03 5.31  0.04
Triglycerides (mmol/l)* 1.65  0.05 1.83  0.06 1.95  0.06 1.91  0.07 1.76  0.10
WBC count† 6.2  0.07 6.6  0.09 7.0  0.09 6.9  0.09 6.9  0.14
Fibrinogen (g/l)† 2.84  0.02 2.87  0.03 3.00  0.03 3.07  0.03 3.13  0.05
hs-CRP (mg/l)† 2.37  0.15 2.13  0.20 2.47  0.21 3.19  0.21 3.00  0.31
Corticosteroid use 22222
Family history of diabetes‡ 26 34 33 33 27
Dental
Mean attachment loss (mm)† 1.4  0.03 2.1  0.04 3.0  0.04 5.0  0.04 NA
Mean PPD (mm)† 2.1  0.02 2.3  0.02 2.7  0.03 3.3  0.03 NA
Decayed, ﬁlled teeth (n)† 6.1  0.08 6.2  0.11 5.6  0.12 4.1  0.12 —§
Decayed, ﬁlled surfaces (n)† 17.3  0.3 16.6  0.4 14.7  0.4 10.6  0.5 —
Tooth count† 22.6  0.2 23.5  0.2 21.5  0.2 16.4  0.2 —
Data are means  SEM or %. *Unadjusted category-speciﬁc value for attachment loss  5 mm. †P  0.01. ‡P  0.05. §Edentulous individuals were excluded from
speciﬁed age- and sex-adjusted regressions because the value of these dependent variables are perfectly correlated with edentulism. NA, not available.
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teeth), and 0.07% (edentulous) (Ptrend 
0.84).
Longitudinal changes in periodontal
status and A1C change
Five-year change in %AL 5m m( AL)
was associated with A1C (supplementary
Figure A3, available in an online ap-
pendix at http://care.diabetesjournals.org/
cgi/content/full/dc09-1778/DC1). When
individuals who were periodontally
healthy at both baseline and follow-up
were compared with individuals who had
poor baseline periodontal health com-
binedwithperiodontaldeteriorationdur-
ing follow-up (ALIV and ALIV), the
respective mean A1C changes in the two
groups were 0.005 vs. 0.143% (P 
0.003). Five-year change in mean PPD
wasnotassociatedwithA1C;A1Cval-
uesacrosscategoriesofmeanPPDchange
were0.03,0.06,0.04,and0.01%,respec-
tively (Ptrend  0.46).
%DFT and A1C change
The %DFT was not correlated with
%AL  5mm (r  0.02, P  0.36).
After multivariable adjustment, A1C pro-
gression across quartiles of %DFT was
0.06, 0.02, 0.05, and 0.03% (Ptrend 
0.70).
CONCLUSIONS — This is the ﬁrst
study to report that a chronic infection
predicts progression of A1C among dia-
betes-free individuals. We report a posi-
tive association between clinical
periodontalstatusand5-yearA1Cchange
among German participants in SHIP.
When compared with participants con-
sidered periodontally healthy, those par-
ticipants with elevated levels of baseline
periodontal disease experienced an ap-
proximate 0.08% greater increase in
A1C during 5 years of follow-up. Dete-
riorating periodontal health during fol-
low-up was also associated with greater
increases in A1C. There was evidence of
an additive effect of baseline and fol-
low-up periodontal status such that par-
ticipants with severe baseline periodontal
diseasecoupledwithlargedeclinesinlon-
gitudinal periodontal health experienced
an 0.13% greater increase in 5-year
A1C relative to participants who were
periodontal healthy at both baseline and
follow-up.Inaddition,theassociationbe-
tween periodontal status and A1C was
strongest among participants with ele-
vated levels of hs-CRP.
These ﬁndings remained after com-
prehensive adjustment for confounders,
which minimized the potential for spuri-
ous associations arising from behavioral/
lifestyle variations across periodontal
disease levels. The results from multivari-
able models suggest that age was a strong
confounder,whereasothercovariateshad
only minimal impact on the results. Ad-
ditional analyses within age strata were
consistent with results from regression
models in the full sample and further
minimized the potential for age-related
confounding.
These data advance previous ﬁndings
from NHANES I, in which elevated levels
of baseline periodontal disease were asso-
ciated with an approximate twofold in-
crease in incident diabetes risk (1).
Speciﬁcally, our data demonstrate a tem-
poral trend in which periodontal disease
predicts an accelerated longitudinal
change in A1C after control for baseline
Table 2—Five-year A1C change estimates derived from multivariable regression modeling:
SHIP, 1997–2006
Variable SD A1C estimate* P value†
Age (years) 15 (years) 0.034 0.12
WHR 0.09 0.049 0.003
Systolic blood pressure (mmHg) 20 0.01 0.38
Triglycerides (mmol/l) 1.34 0.016 0.28
Physical activity (METs) 870 0.011 0.12
WBC count
Quartile 1 Reference
Quartile 2 0.047 0.16
Quartile 3 0.013 0.83
Quartile 4 0.011 0.86
Fibrinogen
Quartile 1 Reference
Quartile 2 0.055 0.15
Quartile 3 0.052 0.27
Quartile 4 0.119 0.02
hs-CRP 1.0 mg/l Reference
1.0  hs-CRP 3.0 mg/l 0.060 0.0001
hs-CRP 3.0 mg/l 0.033 0.23
Periodontal status‡
0 Reference
1–8 0.004 0.87
9–33 0.020 0.30
34–100 0.093 0.001
Edentulous 0.071 0.26
Sex
Female Reference
Male 0.002 0.92
Region
Urban Reference
Rural 0.075 0.30
Smoking status
Never, occasional Reference
Former 0.069 0.002
Current 0.053 0.25
Educational level
10 years Reference
10 years 0.055 0.28
10 years 0.036 0.72
Family history of diabetes (reference 
no history) 0.041 0.08
*Estimates correspond to a 1-SD increase in continuous variables or a change relative to the reference
category.Resultsaresimultaneouslyadjustedforallvariablesincludedinthetable.Participantsmissingdata
for either family history of diabetes, ﬁbrinogen, WBC count, hs-CRP, or hs-CRP 10.0 mg/l were excluded
(n569).†Signiﬁcancelevelsaccountforthestratiﬁed,clusteredsamplingdesigninSHIP.‡Thepercentage
of sites per mouth with attachment loss 5 mm.
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deemed to be diabetes free at baseline us-
ing a standardized diabetes deﬁnition.
Thisresultgreatlyminimizesthepossibil-
itythatelevatedbloodglucoselevelswere
present before and therefore contributed
to periodontal disease observed at
baseline.
The hypothesis that periodontal in-
fections can inﬂuence diabetogenesis is
biologically plausible, and the concept of
inﬂammation-mediatedinsulinresistance
is intriguing (9). Animal models have
demonstrated that virulence factors se-
creted by periodontal pathogens can
stimulate production of inﬂammatory cy-
tokines such as tumor necrosis factor-
(10).Humanstudiesfromthispopulation
(11) and others (12) support the notion
that periodontal infections can induce a
state of low-grade chronic inﬂammation,
and periodontal therapy has been shown
to decrease systemic inﬂammation (13).
Accordingly, tumor necrosis factor- can
induce a state of insulin resistance (14),
and systemic inﬂammation has also
emerged as a novel predictor of incident
diabetes (15,16).
The fact that inﬂammatory adjust-
ments did not remove the association be-
tween periodontal status and A1C
suggeststhatthesevariablesmightbesuf-
ﬁcient but not necessary mediators in the
hypothesized causal path between infec-
tion and diabetogenesis (17). Alterna-
tively, the observation of a potential
interaction between periodontal status
and hs-CRP supports the notion that a
synergistic combination of both oral in-
fectionandsystemicimmuneresponse,as
opposed to a localized oral infection
alone, might be necessary for relevant
metabolic abnormalities to develop.
These subgroup ﬁndings require conﬁr-
mation in other populations.
The observed 0.08% difference in
5-year A1C progression between high
and low levels of periodontal disease is
potentially clinically relevant. This differ-
ence was similar to that observed for a
2-SDincreaseineitherWHRorageinthis
population. Moreover, the difference in
A1C is on the same order of magnitude
as that reported previously for interven-
tion studies from the Diabetes Prevention
Program Research Group (DPPRG) (18).
The DPPRG observed an 0.15% reduc-
tion in A1C over 4 years among diabe-
tes-free participants receiving either
metformin or lifestyle modiﬁcation rela-
tive to participants receiving placebo;
theseA1Cﬁndingstranslatedintoeithera
31% (metformin) or 58% (lifestyle modi-
ﬁcation) reduction in incident diabetes.
Wehaveusedclinicalattachmentloss
as an indirect surrogate of cumulative ex-
posuretoaspeciﬁcarrayofchronicinfec-
tions. Future studies with periodontal
bacterialmeasuresand/orabroaderrange
ofchronicinfectionassessmentcanclarify
the nature of associations between infec-
tion and diabetogenesis; these ap-
proaches have been illuminating for
cardiovascular disease (19,20). Data on
the association between periodontal sta-
tus and fasting blood glucose levels can
further inform our current ﬁndings,
which were limited to A1C.
The ﬁnding that caries were not asso-
ciatedwithA1Cenhancesthespeciﬁcity
of the oral infection hypothesis. Although
caries also have a bacterial etiology, they
are not typically known to inﬂuence sys-
temic inﬂammation (21).
The observation that edentulous par-
ticipants demonstrated mean A1C in-
creases similar to those of dentate
participants with periodontal disease
might appear counterintuitive to the con-
cept of systemic risk induced by bacterial
bioﬁlms on tooth surfaces. However,
theseﬁndingsareconsistentwiththoseof
others who have shown edentulous par-
ticipants to be at elevated risk for athero-
sclerosis (7,8), hypertension (22), and
diabetes (1). Desvarieux et al. (8) have
suggested that once infection-induced
systemic damage has occurred, it is not
entirelyreversible.Alternatively,systemic
inﬂammation related to oral infections
mightnotabateafterresolutionofclinical
disease. It is also possible that repeated
bacteremic events occurring before ex-
traction of periodontally affected teeth
(23) might allow oral pathogens to colo-
nize systemically. Indeed, viable oral
pathogens have been identiﬁed in athero-
matous plaques (24). Therefore, once
bacterial species have colonized the host,
tooth extraction, by itself, should not af-
fect their future viability and/or pathoge-
nicity. Although these concepts are
speculative and cannot be tested in the
current study, they are biologically plau-
Table 3—A1C change across increasing categories of baseline periodontal disease (of sites with attachment loss >5 mm): SHIP, 1997–2006
Model
ALI
(0  0%)*
ALII
(4  2%)*
ALIII
(18  7%)*
ALIV
(62  21%)* Edentulous P value†
n 1,122 488 463 479 241
1 0.035  0.017 0.017  0.026 0.097  0.025 0.162  0.029 0.225  0.047 0.001
2 0.017  0.018 0.022  0.026 0.071  0.026 0.109  0.030 0.130  0.051 0.009
3 0.020  0.018 0.023  0.026 0.064  0.026 0.105  0.030 0.136  0.050 0.013
4 0.023  0.018 0.023  0.027 0.065  0.026 0.106  0.030 0.124  0.052 0.025
5 0.020  0.017 0.020  0.024 0.080  0.022 0.090  0.028 0.143  0.048 0.011
6 0.032  0.039 0.029  0.035 0.043  0.040 0.107  0.042 0.110  0.073 0.02
7 0.024  0.026 0.021  0.031 0.045  0.029 0.117  0.040 0.100  0.052 0.05
8 0.012  0.018 0.019  0.023 0.071  0.026 0.098  0.026 0.101  0.043 0.013
9 0.012  0.017 0.014  0.022 0.061  0.024 0.088  0.026 0.071  0.041 0.038
10 0.022  0.015 0.012  0.019 0.039  0.022 0.068  0.022 0.031  0.034 0.008
Data are means  SEM. Model 1: unadjusted. Model 2: adjusted for age, sex, and region. Model 3: model 2 	 smoking and WHR. Model 4: model 3 	 education,
systolic blood pressure, triglycerides, and physical activity (n  10 participants excluded because of missing triglyceride data). Model 5: model 4 	 natural log of
baselineA1C.Model6:model4	hs-CRP,WBCcount,ﬁbrinogen,andcorticosteroiduse(n146participantsexcludedbecauseofmissingdataonhs-CRP,WBC
count, or ﬁbrinogen; additional n  78 excluded due to hs-CRP 10 mg/l). Model 7: model 6 	 family history of diabetes (parent or sibling; n  408 participants
excludedbecauseofuncertainfamilyhistory)(n54participantsreportedcorticosteroiduse).Model8:model4adjustmentsremovingn8participantswithA1C
change 3.0 or 3.0. Model 9: model 4 adjustments removing n  21 participants with A1C change 2.0 or 2.0. Model 10: model 4 adjustments removing
n  157 participants with A1C change 1.0 or 1.0. *Category-speciﬁc value for adjustment loss 5 mm. †P value for linear trend across dentate participants.
All SEMs and signiﬁcance levels account for the stratiﬁed, clustered sampling design in SHIP.
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literature.
We have found elevated levels of peri-
odontal disease, as well as progression of
periodontaldisease,tobepredictorsofA1C
progression in a randomly sampled, popu-
lation-based study of Germans over 5 years
of follow-up. These data support the hy-
pothesis that chronic infections might con-
tribute to diabetogenesis. We await
longitudinal results from year 10 in SHIP,
which will allow us to determine whether
thesesubclinicalA1Cchangestranslateinto
increased risk for incident diabetes. Fo-
cusedinterventionstudieswillbenecessary
to make deﬁnitive causal inference regard-
ing the potential role of anti-infective ther-
apy in reducing the risk of diabetes. If
conﬁrmed, this relationship would be of
substantial public health importance, given
the population prevalence of periodontal
infections (25) and the availability of effec-
tive periodontal disease therapies.
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